PepGen Inc (PEPG)
PepGen Market Cap: 477.99M for May 23, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 22, 2024 | 455.79M |
May 21, 2024 | 450.27M |
May 20, 2024 | 437.31M |
May 17, 2024 | 426.61M |
May 16, 2024 | 442.49M |
May 15, 2024 | 448.01M |
May 14, 2024 | 453.52M |
May 13, 2024 | 431.15M |
May 10, 2024 | 454.16M |
May 09, 2024 | 432.45M |
May 08, 2024 | 444.12M |
May 07, 2024 | 452.54M |
May 06, 2024 | 452.22M |
May 03, 2024 | 460.32M |
May 02, 2024 | 469.73M |
May 01, 2024 | 450.60M |
April 30, 2024 | 397.75M |
April 29, 2024 | 378.32M |
April 26, 2024 | 386.42M |
April 25, 2024 | 378.97M |
April 24, 2024 | 383.18M |
April 23, 2024 | 379.62M |
April 22, 2024 | 368.93M |
April 19, 2024 | 341.22M |
April 18, 2024 | 383.65M |
Date | Value |
---|---|
April 17, 2024 | 372.48M |
April 16, 2024 | 407.78M |
April 15, 2024 | 396.12M |
April 12, 2024 | 421.06M |
April 11, 2024 | 411.67M |
April 10, 2024 | 385.43M |
April 09, 2024 | 393.21M |
April 08, 2024 | 400.33M |
April 05, 2024 | 385.11M |
April 04, 2024 | 375.39M |
April 03, 2024 | 352.07M |
April 02, 2024 | 422.68M |
April 01, 2024 | 469.00M |
March 28, 2024 | 475.61M |
March 27, 2024 | 455.87M |
March 26, 2024 | 424.81M |
March 25, 2024 | 429.99M |
March 22, 2024 | 482.41M |
March 21, 2024 | 478.52M |
March 20, 2024 | 481.11M |
March 19, 2024 | 451.99M |
March 18, 2024 | 441.64M |
March 15, 2024 | 499.55M |
March 14, 2024 | 450.05M |
March 13, 2024 | 444.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Catalyst Pharmaceuticals Inc | 1.892B |
Vertex Pharmaceuticals Inc | 116.73B |
Sarepta Therapeutics Inc | 12.10B |
PTC Therapeutics Inc | 2.915B |
Regenxbio Inc | 751.65M |
Market Cap Related Metrics
Price to Book Value | 2.670 |
Price | 14.74 |
Earnings Yield | -21.97% |